Phase Ii Evaluation of Three-Day Topotecan in Recurrent Platinum-Sensitive Ovarian Carcinoma: A Gynecologic Oncology Group Study
AuthID
P-00V-T4J
P-00V-T4J
© 2024 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service